Showing results (1901-1910 of 1,933) with videos related to
Sort By:
Pageof 194
JAMA Internal Medicine|December 29, 2018
Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary SyndromeJi-Yan Chen, Peng-Cheng He, Yuan-Hui Liu, et al.Bioorganic & Medicinal Chemistry|January 7, 2014
Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitorsYonghui Wang, Wei Cai, Guifeng Zhang, et al.Plos Pathogens|August 3, 2026
Structural and functional characterization of a conserved cryptic epitope on SARS-CoV-2 spike S2 subunitLing Zhou, Ching-Lin Hsieh, Sarah R Leist, et al.Current Medical Research and Opinion|April 20, 2018
Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort studyZhi-Hong Liu, Xue-Qing Yu, Jun-Wei Yang, et al.Ebiomedicine|April 11, 2025
Molecular heterogeneity of CD30+ peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre studyYu-Jia Huo, Shu Cheng, Hong-Mei Yi, et al.Journal of Hepatology|November 10, 2022
Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosisXiaofeng Zhang, Jiankang Song, Yuanjian Zhang, et al.Science Translational Medicine|December 10, 2025
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153Ida Paciello, Emily J Rundlet, Ling Zhou, et al.The Lancet. Rheumatology|January 17, 2024
IBI303, a biosimilar to adalimumab, for the treatment of patients with ankylosing spondylitis in China: a randomised, double-blind, phase 3 equivalence trialHuji Xu, Zhijun Li, Jian Wu, et al.Circulation. Cardiovascular Interventions|June 5, 2015
Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathyYong Liu, Ji-Yan Chen, Ning Tan, et al.Clinical and Molecular Hepatology|July 4, 2025
Human cytomegalovirus reactivation in cirrhosis patients with acute decompensationChangze Hong, Zuxiong Huang, Yingli He, et al.Pageof 194